Sumati Morarjee

Recent publications · Crossref

5 total works indexed

1. Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition

   · 2013 · cited 1,088x

2. A Comparative Review of Generic Quality-of-Life Instruments

   · 2000 · cited 605x

3. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

   · 2021 · cited 569x

4. A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells

   · 1999 · cited 568x

5. Recruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor

   · 1996 · cited 444x

via Crossref · CC0

Wikidata facts

Image